Afficher la notice abrégée

dc.contributor.authorONWUCHEKWA, CHINEDU
dc.date.accessioned2018-10-12T09:41:59Z
dc.date.accessioned2019-10-04T10:01:11Z
dc.date.available2018-10-12T09:41:59Z
dc.date.available2019-10-04T10:01:11Z
dc.date.issued2011-03
dc.identifier.urihttps://library.adhl.africa/handle/123456789/12315
dc.descriptionA RESEARCH PROJECT SUBMITTED TO THE DEPARTMENT OF PHYSIOLOGY, COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN, IN PARTIAL FULFILLMENT OF REQUIREMENT FOR THE MASTER OF PHILOSOPHY (PHYSIOLOGY) (MPhil.) DEGREE OF THE UNIVERSITY OF IBADAN, NIGERIA.en_US
dc.description.abstractBetulinic acid (BA) is a lupane-type triterpene that has been identified and isolated from different plant species used in ethnomedicine worldwide. It is known to possess anti-ulcer, anti-tumor and anti-microbial properties. However, the mechanism underlying the anti-ulcer property of BA has not been well investigated. The effect of BA on indomethacin-induced peptic ulcer, gastric mucus secretion (GMS), gastric mucus cell count (GMCC), basal and histamine induced gastric acid secretion (GAS), and malondialdehyde (MDA) concentration level were studied as means of elucidating the mechanism. Thirty-two rats divided into four groups of eight rats each were used for each study. Group I (Control) was pretreated orally with dimethyl sulfoxide (DMSO) in normal saline for seven days. Groups II, III and IV were pretreated orally with BA (0.5 mg/kg, 1.5 mg/kg, and 3.0 mg/kg) dissolved in DMSO respectively for seven days. Gastric ulceration was induced using indomethacin and scored by ulcer scoring technique. Measurement of GMS was performed using spectrophotometric method, while GMCC was done by using calibrated microscopy. Continuous perfusion technique was used to assess GAS and its acidity determined by titration. Histological study of the stomach mucosa was also carried out. MDA levels were determined by measuring thiobarbituric acid reactive substances produced. Data were expressed as Mean ± SEM. Student’s t-test and one way ANOVA were used to determine levels of significance at p<0.05. There was a dose - dependent reduction in ulcer scores in the BA treated animals. This reduction was significant at doses of 1.5mg/kg (0.75  0.10) and 3.0mg/kg (0.25  0.09) compared to the control (7.0  0.27). GMS (mg/g tissue x 10-2) significantly increased in the 1.5 mg/kg (4.9 ± 0.22) and 3.0 mg/kg (5.2 ± 0.09) pretreated groups compared to the control (4.4 ± 0.20) group. There was also a dose-dependent significant increase in the GMCC/mm2 of rats treated with 0.5 mg/kg (44.4 ± 0.84); 1.5 mg/kg (45.9 ± 0.79); 3.0 mg/kg (54.1± 0.71)] compared with the control group (41.4 ± 0.71). The histamine-induced GAS was significantly higher than the basal GAS. However, there was a significant decrease in GAS of BA treated groups compared with the control. Histological study showed significant hyperplasia of mucus cells in BA treated groups compared to the control group. There was a significant decrease in MDA (μmol/L x 10-6) levels in groups II, III and IV (1.86± 0.076, 1.83 ± 0.069 and 1.10 ± 0.056) compared to the control (2.60 ± 0.110) group. The results of the study suggest that betulinic acid produces anti-ulcer effect by increasing gastric mucus secretion, gastric mucus cell count and decreasing malonialdehyde concentration. It decreases gastric acid secretion via the blocking of H2-receptors.en_US
dc.language.isoenen_US
dc.subjectBetulinic aciden_US
dc.subjectgastric ulceren_US
dc.subjectmalondialdehydeen_US
dc.subjectgastric mucus secretionen_US
dc.titleMECHANISM OF ANTI-GASTRIC ULCER EFFECT OF BETULINIC ACID IN MALE ALBINO RATSen_US
dc.typeThesisen_US


Fichier(s) constituant ce document

FichiersTailleFormatVue
ui_thesis_Onwuc ... 11_mechanism_full_work.pdf7.161Moapplication/pdfVoir/Ouvrir

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée